We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+8.06%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$267M
AUM Growth
+$9.19M
Cap. Flow
-$4.55M
Cap. Flow %
-1.7%
Top 10 Hldgs %
67.14%
Holding
56
New
2
Increased
4
Reduced
30
Closed
8

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$226K
2
AEP icon
American Electric Power
AEP
+$196K
3
PANW icon
Palo Alto Networks
PANW
+$88.3K
4
LLY icon
Eli Lilly
LLY
+$26.6K
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.52K

Top Sells

Rank Stock Value
1
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$864K
2
VMW
VMware, Inc
VMW
+$549K
3
URGN icon
UroGen Pharma
URGN
+$342K
4
AAPL icon
Apple
AAPL
+$324K
5
ISRG icon
Intuitive Surgical
ISRG
+$297K

Sector Composition

Rank Sector Weight
1 Technology 35.74%
2 Consumer Discretionary 28.37%
3 Healthcare 24.05%
4 Communication Services 8.46%
5 Utilities 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMMT icon
51
Summit Therapeutics
SMMT
$10.5B
– –
-14,059
Closed -$17K
URGN icon
52
UroGen Pharma
URGN
$2.02B
– –
-41,131
Closed -$342K
CMRX
53
DELISTED
Chimerix, Inc.
CMRX
– –
-10,609
Closed -$20K
BBIG
54
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
– –
-4,000
Closed -$74K
JNCE
55
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-10,000
Closed -$23K
CLVS
56
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-50,000
Closed -$60K
1 2
3

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
KPWG
KFA Private Wealth Group Tysons, Virginia $417M AUM 16.82% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return

Bender Robert & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Bender Robert & Associates held 56 positions worth $267M, up 3.6% from $258M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Bender Robert & Associates's Q4 2022 filing shows 2 new, 4 increased, 30 reduced and 8 closed positions. Its largest new stake was Visa: 1,120 shares worth $233K. The largest sale was BioCryst Pharmaceuticals, an estimated $864K.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates's largest Q4 2022 buy was Visa: 1,120 shares worth $233K.
  • Bender Robert & Associates added most to Palo Alto Networks in Q4 2022, an estimated $88.3K increase.
  • Bender Robert & Associates's biggest Q4 2022 reduction was VMware, Inc, cutting an estimated $549K.
  • Bender Robert & Associates fully exited BioCryst Pharmaceuticals in Q4 2022, selling an estimated $864K.
  • Bender Robert & Associates's ten largest holdings make up 67% of its $267M portfolio in Q4 2022.
  • Bender Robert & Associates opened 2 new positions and closed 8 in Q4 2022.
  • Bender Robert & Associates's portfolio value rose 3.6% quarter-over-quarter to $267M.

Based on Bender Robert & Associates's 13F filing for Q4 2022, filed 2 Feb 2023.